Daewoong Pharmaceutical Co., Ltd. has signed a 29.5 billion won ($22.2 million) export deal with M8 (Moksha8) to supply its botulinum toxin Nabota to Mexico, expanding its reach across Latin America's top five aesthetic markets and highlighting significant growth potential in the region.
#YonhapInfomax #DaewoongPharmaceutical #Nabota #ExportDeal #MexicoMarket #BotulinumToxin #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=102961